GREAT TIME TO BUY AVCT9 Jun 2020 16:15
Update on Thursday and two webinars, must be important news!!
TURNER POPE & VOX at 14:00
Investor Presentation
Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that Alastair Smith, Chief Executive Officer, will be presenting at an investor webinar being hosted jointly by Turner Pope Investments (TPI) Ltd and Vox Markets.The event will be held on Thursday, 11 June 2020 at 2pm.Please register your interest
hTtps://tinyurl.com/ydh2z6qe
PROACTIVE at 18:00
Proactive's One2One Virtual Forum - Thursday 11th June from 6:00pm [GMT] onwards via our YouTube channel and online interactive webinar conference. Hosted by Proactive's Andrew Scott.
Meet:
MaxCyte Inc. (LON:MXCT)
ReNeuron Group PLC (LON:RENE)
Arix Bioscience (LON:ARIX)
Avacta Group PLC (LON:AVCT)
hTtps://tinyurl.com/ycpvrm83